Accession Number: | 0001209191-21-042768 |
Date: | 2021-06-22 |
Issuer: | CRINETICS PHARMACEUTICALS, INC. (CRNX) |
Original Submission Date: |
NICHOLS WESTON
C/O CRINETICS PHARMACEUTICALS, INC.
10222 BARNES CANYON ROAD, BLDG 2
SAN DIEGO, CA 92121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 20.23 | 2021-06-22 | deemed execution date | A | 17,500 (a) | 2031-06-21 | common stock 17,500 | $20.23 | 17,500 | direct |
ID | footnote |
---|---|
f1 | the entire number of shares subject to this option become fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the issuer's stockholders, subject to the reporting person's continued service on the board of directors of the issuer through such vesting date. |